Hematopoietic cell transplantation (HCT) is an intensive, medically complicated and potentially life-threatening therapy with a prolonged trajectory of recovery. Like financial toxicity in cancer, adverse financial consequences of HCT are emerging as an important issue, and may be associated with poor quality of life and increased distress in HCT survivors. 1, 2 Financial burden is difficult to assess quantitatively as it is influenced by an individual's perception of what he or she considers to be a burden. Qualitative research methods can be used to collect information about patients' perceptions of reasons for their financial distress and to ask them what tangible support would benefit them. This can eventually help to design intervention studies.
In our pilot study evaluating financial burden after HCT, we used a qualitative research methodology to reach a deeper and richer understanding of patients' perceptions about financial difficulties as a result of HCT. A 25-item self-administered questionnaire was mailed to 482 study patients who had received an allogeneic HCT between January 2006 and June 2012 at the three Mayo Clinic sites: Rochester (MN), Phoenix (AZ) and Jacksonville (FL) and were alive, with a current address available. The study was approved by the Institutional Review Board at Mayo Clinic. The survey methodology and quantitative results have been described in detail previously. 1 The questionnaire included an open-ended question: 'How has transplant made an impact on your financial situation? Please let us know if any particular information could have been provided to you before the transplant that would have helped you plan your finances better for your post-transplant care'. The textual data obtained from this question from 46% of the 268 respondents (n = 124) were analyzed with a constant comparative analysis. There were no significant differences in sociodemographic characteristics of this subset and the respondents who did not provide narrative comments (Table 1) . Two qualitative researchers and one clinician familiar with qualitative analysis techniques coded the transcripts generated and arrived at the codes after mutual discussion. In addition, qualitative reliability and validity criteria suggested by Creswell and Plano Clark were utilized to ensure data triangulation and inter-coder agreement.
3 Table 2 includes some representative responses for the seven themes that emerged from the constant comparative analysis of 124 patient comments. Participants shared vivid accounts of devastating financial loss after HCT such as that of their home/ business, need to declare bankruptcy or loss of retirement income, a decrease in household income and depleted savings. Dichotomies such as 'painful but worth it' and 'grateful to be alive, yet HCT created a financial strain' were apparent in some patient expressions. Participants worried about lifetime caps on insurance, changes in self/spouses' health insurance, health insurance coverage running out and concerns about paying all the bills or not being able to afford everything. Prolonged inability to go back to work because of long-term complications in the face of continued medical expenses increased the financial burden for some people.
A quarter of the commentators described resources such as savings, retirement funds, self or spouses insurance and financial support, supportive employer with good benefits, temporary housing coverage, fundraisers and donations from family and friends that assisted with their finances. While having good insurance was supportive for some patients, problems with health insurance created stress for others. Navigation of the health care insurance system was described as challenging by some of the commenters. Impact on caregivers was evidenced by concerns about employment and the financial situation of the whole household as a result of patients' HCT. It was apparent from the comments that though the primary focus of patients was on treatment and physical and emotional well-being as compared with financial well-being at the time of transplant, there was a desire to have a frank discussion about possible financial consequences. As a highly complex medical treatment for various hematological malignancies, HCT is associated with multiple psychosocial issues during recovery, and financial burden is clearly one of them. Our qualitative data suggest that employment, health insurance and government policies may be important factors with contrasting impact on the degree of financial burden for patients and families. They could exacerbate the burden for some, but ameliorate it for others similar to what has been reported by other investigators in this area.
2,4-6 In addition, patients reflected on the need for financial planning before HCT because of ongoing medical complications adding to the financial burden, consistent with the approach recommended by Majhail et al. 7 Patients recognized navigating the system and lack of knowledge about employment or insurance policies as a big challenge. They appreciated the involvement of social workers and other providers who performed pre-HCT financial screening and counseling and assisted them with financial issues during the course of their HCT.
Unlike other medical conditions, HCT is usually undertaken for a life-threatening disease, which for most people decreases the priority of financial concerns during the initial decision-making. This dilemma was well-reflected in one of the patient comments: I believe everything was explained thoroughly and explicitly. But I don't think that when you face a last option to have a decent quality of life that you process it. You hear, understand and acknowledge it but only when you are on the other side of transplant, do you allow your mind and heart to process the knowledge that it may cost everything you own. When hope reappears, you process it because then you have a value to balance it against.
Our analysis has limitations. Using the question and answer format only from the respondents who gave narrative comments did not allow for further in-depth exploration of the perspectives of the participants and may have resulted in selection of a specific subset precluding the capture of diversity of perceptions. However, the commentators and non-commentators were quite comparable in terms of their sociodemographic profile. This is also being addressed by our group in a future project, which includes brief semi-structured interviews with HCT survivors trying to assess financial stressors after HCT. The survey was sent to patients who were alive at the time and therefore, may be an underestimate of financial burden as burden experienced by families of patients who died may be higher with the end-of-life care that they receive. We also acknowledge that this was a single institution study (albeit form three distinct geographic sites) from the USA and results might vary depending on payer system and government policies in other countries.
Notwithstanding these limitations, our data provide critical information on inter-related factors associated with financial burden from patients' points of view and suggests the need for 
Financial loss
• The transplant-related expenses have driven us to near bankruptcy. Even with double coverage health insurance, medical supplies and services, travel expenses have used up all of our financial resources. I am still unable to work and have tens of thousands of dollars owed to credit cards and hospitals. Bankruptcy is inevitable, unavoidable.
• We had to file Chapter 7 (bankruptcy)…and we were in the middle of treatment which was really hard to deal with.
• We may lose our business and home due to my illness. Additionally, my wife of 16 years is now thinking of divorce. Quite a story, I survive cancer-leukemia-a transplant and lose my wife and business.
Financial worry • For some reason the previous years' finances are not squared away yet. We are a little nervous about this. Will we have an enormous unforeseen bill due someday? • I'm terrified that after my spouse's health insurance company changes that the insurance will not be accepted by the hospital, this would be a financial disaster.
Employment loss and transition
• Post-transplant issues have put serious limits on what kind of work I can do and how much I can do-so income earning ability is seriously depleted.
Health care and insurance barriers • In preparation for my transplant I made several calls to my insurance company and the hospital. It was difficult to get a straight answer on (1) what a transplant would cost (2) how much the insurance company would cover and (3) if the hospital and the insurance company would work together. This added to my stress.
Financial facilitators
• I think the financial needs after release and transplants were quite high. My family raised income to assist in rent and food and gas money….
• I'd be bankrupt without my husband's insurance and support.
• The Gift of Life Transplant House was a great asset in keeping our lodging costs manageable during the transplant process.
• My church helped with my mortgage payment.
Preparation for financial consequences of HCT • No way to plan, we could only focus on her treatment plans. Finances were last, left us unprepared to deal with all the consequences.
• Though I was prepared for the cost of the transplant itself, I never imagined that medical and prescription costs post transplant would have amounted to so much.
Impact on family/caregiver • My husband's employer let him go after his 12 week FMLA [Family and Medical Leave Act] was over. We were still in Phoenix post transplant and he was my caregiver.
• My wife had to give up her full-time job to help meet all the requirements added to her schedule because of my inability to help like I used to, plus doctor appointments, etc. Childcare expenses added to financial burden.
inquiry and intervention before and after transplant to identify at-risk patients. This would likely improve psychosocial outcomes including quality of life and overall patient satisfaction. 8 Our findings reinforce the need for revising the policies regarding employment and benefits or policies related to it and improving the quality of insurance coverage delivery since these are integrally related to financial burden for most of the patients. Future research should aim to develop measures that can be incorporated in regular assessments to evaluate financial impact on patients and to help identify the vulnerable groups. 9 There is also a need for developing interventions such as utilizing a patient navigator to help with employment/insurance-related issues or a financial planner to help patients understand the financial impact better and plan to avoid catastrophic financial consequences for themselves and their families.
